Drugs of abuse: teratogenic and mutagenic considerations.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000284:Administration, Oral; D001711:Biotransformation; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000378:metabolism; D005865:Gestational Age; D006801:Humans; D008099:Liver / Q000378:metabolism; D008431:Maternal-Fetal Exchange; D008970:Molecular Weight; D009153:Mutagens; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D013045:Species Specificity; D019966:Substance-Related Disorders / Q000150:complications*; D013723:Teratogens / Q000008:administration & dosage
D009153:Mutagens; D013723:Teratogens